Literature DB >> 9972694

Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex.

M M Faraday1, V A O'Donoghue, N E Grunberg.   

Abstract

We recently reported that 14 days of nicotine administration (12 mg/kg/day) reduced acoustic startle reflex amplitude and impaired prepulse inhibition (PPI) of startle in male and female Long-Evans rats. These findings contrasted with reports of nicotine-induced enhancement of startle and PPI in Sprague-Dawley (a different strain) male rats. The present experiment administered 0, 6, or 12 mg/kg/day nicotine via osmotic minipump for 14 days to 120 Sprague-Dawley rats (male and female) and to 120 Long-Evans rats (male and female) and examined ASR and PPI. Half of the subjects also were stressed by immobilization once each day to examine nicotine-stress interactions. Nicotine enhanced ASR and PPI responses of Sprague-Dawley rats but impaired these responses in Long-Evans rats, regardless of sex. Effects of stress were complex and depended on strain, sex, and drug dose. These findings indicate that effects of nicotine on measures of reactivity (ASR) and sensory gating (PPI) depend on genotype and that nicotine stress interactions depend on genotype, sex, and nicotine dosage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9972694     DOI: 10.1016/s0091-3057(98)00159-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  31 in total

1.  Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor.

Authors:  Jane E Sutherland; Lisa H Conti
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

2.  Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits?

Authors:  Vaishali P Bakshi; Karen M Alsene; Patrick H Roseboom; Elenora E Connors
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

3.  Fear-potentiated startle to threat, and prepulse inhibition among young adult nonsmokers, abstinent smokers, and nonabstinent smokers.

Authors:  Christian Grillon; Shelli Avenevoli; Elsa Daurignac; Kathleen R Merikangas
Journal:  Biol Psychiatry       Date:  2007-06-01       Impact factor: 13.382

4.  Interaction between the effects of corticotropin-releasing factor and prepulse parameters on prepulse inhibition in two inbred rat strains and the F1 generation of a cross between them.

Authors:  Lisa H Conti; Jane E Sutherland; Carey M Muhlhauser
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

5.  Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Authors:  L Elliot Hong; Gunvant K Thaker; Robert P McMahon; Ann Summerfelt; Jill Rachbeisel; Rebecca L Fuller; Ikwunga Wonodi; Robert W Buchanan; Carol Myers; Stephen J Heishman; Jeff Yang; Adrienne Nye
Journal:  Arch Gen Psychiatry       Date:  2011-08-01

6.  Withdrawal from chronic nicotine in adolescent and adult rats.

Authors:  Carrie E Wilmouth; Linda P Spear
Journal:  Pharmacol Biochem Behav       Date:  2006-12-14       Impact factor: 3.533

7.  Effects of intravenous nicotine on prepulse inhibition in smokers and non-smokers: relationship with familial smoking.

Authors:  David J Drobes; David A MacQueen; Melissa D Blank; Michael E Saladin; Robert J Malcolm
Journal:  Psychopharmacology (Berl)       Date:  2013-04-28       Impact factor: 4.530

8.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

9.  Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women.

Authors:  Veena Kumari; Joanna Konstantinou; Andrew Papadopoulos; Ingrid Aasen; Lucia Poon; Rozmin Halari; Anthony J Cleare
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

10.  Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients.

Authors:  L Elliot Hong; Ikwunga Wonodi; Jada Lewis; Gunvant K Thaker
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.